Bioverge
Early Stage
Fusing sci-fi with fintech through a health + tech investment platform
Overview
Raised: $138,007
Total Commitments ($USD)
Platform
Republic
Start Date
05/12/2023
Close Date
08/07/2023
Min. Goal
$25,000
Max. Goal
$1,235,000
Min. Investment
$100
Security Type
SAFE
Series
Seed
SEC Filing Type
RegCF
Early Bird Val. Cap
$18,000,000
Valuation Cap
$25,000,000
Discount
20%
Rolling Commitments ($USD)
Status
Funded
Reporting Date
08/31/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,586
# of Investors
251
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Financial & Insurance Products & Services
Tech Sector
Fintech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
Low
Bioverge, with a valuation of $25 million, is raising funds on Republic. The company has developed a health technology investment platform to merge sci-fi with fintech. The platform is democratizing investing in curated healthcare technology startups with its portfolio of 37 companies with a value of over $3 billion. Bioverge offers a variety of investment options, including deal-by-deal investments, Bioverge Access funds, and thematic funds. Neil Littman and Rick Gibb founded Bioverge in August 2017. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for product development, sales and marketing, new hires, and working capital.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$247,786 |
$251,720 |
|
COGS |
$49,972 |
$26,101 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-406,203 |
$-591,903 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$324,314 |
$487,668 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$567,769 |
$751,759 |
|
Short-Term Debt |
$52,668 |
$178,120 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$52,668 |
$178,120 |
Financials as of: 05/12/2023
Create a free account today to gain access to KingsCrowd analytics.
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Bioverge | 08/07/2023 | Republic | $25,000,000 | $138,007 | SAFE | Funded | RegCF |
| Bioverge | 02/28/2022 | Netcapital | $10,014,900 | $710,266 | Equity - Common | Funded | RegCF |
| Bioverge | 05/13/2021 | Netcapital | $10,014,900 | $0 | Equity - Common | Funded | Test the Waters / RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.